These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21911454)

  • 1. Progression of human bronchioloalveolar carcinoma to invasive adenocarcinoma is modeled in a transgenic mouse model of K-ras-induced lung cancer by loss of the TGF-β type II receptor.
    Borczuk AC; Sole M; Lu P; Chen J; Wilgus ML; Friedman RA; Albelda SM; Powell CA
    Cancer Res; 2011 Nov; 71(21):6665-75. PubMed ID: 21911454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness.
    Borczuk AC; Kim HK; Yegen HA; Friedman RA; Powell CA
    Am J Respir Crit Care Med; 2005 Sep; 172(6):729-37. PubMed ID: 15976377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II.
    Page JM; Merkel AR; Ruppender NS; Guo R; Dadwal UC; Cannonier S; Basu S; Guelcher SA; Sterling JA
    Biomaterials; 2015 Sep; 64():33-44. PubMed ID: 26115412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
    Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
    Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
    Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL
    Genes Dev; 2006 Nov; 20(22):3147-60. PubMed ID: 17114585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES.
    Borczuk AC; Papanikolaou N; Toonkel RL; Sole M; Gorenstein LA; Ginsburg ME; Sonett JR; Friedman RA; Powell CA
    Oncogene; 2008 Jan; 27(4):557-64. PubMed ID: 17653092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
    Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
    Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
    Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epigenetic auto-feedback loop regulates TGF-β type II receptor expression and function in NSCLC.
    Yang S; Cho YJ; Jin L; Yuan G; Datta A; Buckhaults P; Datta PK
    Oncotarget; 2015 Oct; 6(32):33237-52. PubMed ID: 26356817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.
    Fang WB; Jokar I; Chytil A; Moses HL; Abel T; Cheng N
    Clin Exp Metastasis; 2011 Apr; 28(4):351-66. PubMed ID: 21374085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
    Bjerke GA; Pietrzak K; Melhuish TA; Frierson HF; Paschal BM; Wotton D
    PLoS One; 2014; 9(3):e92800. PubMed ID: 24651496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
    Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
    Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tgf-beta signaling pathway in lung adenocarcinoma invasion.
    Toonkel RL; Borczuk AC; Powell CA
    J Thorac Oncol; 2010 Feb; 5(2):153-7. PubMed ID: 20101143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
    Guo Y; Jacobs SC; Kyprianou N
    Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
    Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
    Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma.
    Malkoski SP; Haeger SM; Cleaver TG; Rodriguez KJ; Li H; Lu SL; Feser WJ; Barón AE; Merrick D; Lighthall JG; Ijichi H; Franklin W; Wang XJ
    Clin Cancer Res; 2012 Apr; 18(8):2173-83. PubMed ID: 22399565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.
    Ijichi H; Chytil A; Gorska AE; Aakre ME; Bierie B; Tada M; Mohri D; Miyabayashi K; Asaoka Y; Maeda S; Ikenoue T; Tateishi K; Wright CV; Koike K; Omata M; Moses HL
    J Clin Invest; 2011 Oct; 121(10):4106-17. PubMed ID: 21926469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.
    Sarkaria IS; Pham D; Ghossein RA; Talbot SG; Hezel M; Dudas ME; Ebright MI; Chuai S; Memoli N; Venkatraman ES; Miller VA; Kris MG; Zakowski MF; Rusch VW; Singh B
    Ann Thorac Surg; 2004 Nov; 78(5):1734-41. PubMed ID: 15511464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.